Healthcare -
Biotechnology - NASDAQ - US
$ 2.95
-10.3 %
$ 2.15 B
Market Cap
-3.28
P/E
IBRX - SHORT-TERM DEBT
Short-term Debt IBRX - ImmunityBio, Inc.
5.24 M
LAST VALUE
-86.89%
2 YEAR CAGR
40.29%
5 YEAR CAGR
11.54%
10 YEAR CAGR